Health Condition 1: L20-L30- Dermatitis and eczema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female participants aged 10 to 55 years. 2. Clinical diagnosis of mild to moderate dandruff, defined by a Flake Severity Score (FSS) of 1–3. 3. Willingness to abstain from using any other hair care or anti-dandruff products throughout the study duration. 4. Voluntary participation with written informed consent.
Exclusion criteria
Exclusion criteria: 1. Participants with other known scalp disorders (e.g., psoriasis, seborrheic dermatitis, tinea capitis). 2. Individuals with known hypersensitivity or allergy to any of the shampoo components. 3. Use of systemic corticosteroids, antifungals, or antibiotics in the past 4 weeks. 4. Participation in another clinical study in the last 30 days. 5. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Dandruff Severity Index (DSI; 0–9, clinician-rated) from baseline (Day 0) to end of treatment (Day 21).Timepoint: Day 0 (Baseline), Days 1–7 (daily symptom/safety tracking), Day 7, Day 14, and Day 21 (end of treatment). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pruritus Assessment (VAS) 2. Subjective Hair Manageability Questionnaire 3. Wet Combability Test 4. Ocular Irritation Scale 5. Investigator Global Assessment (IGA) 6. Subject Self-Assessment Questionnaire 7. Hair Strand Health Assessment 8. Cosmetic Outcome Evaluation Timepoint: Day 0 (Baseline), Days 1–7 (daily symptom/safety tracking), Day 7, Day 14, and Day 21 (end of treatment). | — |
Countries
India
Contacts
Pankajakasthuri Ayurveda Medical college and PG centre